Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

Publication Type:

Journal Article


JAMA : the journal of the American Medical Association, Volume 303, Issue 17, p.1729-37 (2010)


2010, Antineoplastic Agents, Center-Authored Paper, Chemotherapy, Adjuvant, Combined Modality Therapy, Consortium Authored Paper, Humans, Public Health Sciences Division, Randomized Controlled Trials as Topic, Stomach Neoplasms, Survival Analysis, Treatment Outcome


Despite potentially curative resection of stomach cancer, 50% to 90% of patients die of disease relapse. Numerous randomized clinical trials (RCTs) have compared surgery alone with adjuvant chemotherapy, but definitive evidence is lacking.